Anand Kumar
Gastroenterology · Philadelphia, PANPI 1962663088
Payments from drug & device makers
Across 77 payments — averaging $251.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conmed Corporation$6K
- Boston Scientific$5K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$4K
- Olympus Corporation$3K
- Fujifilm Healthcare Americas Corporation$472
- Pentax Of America, Inc.$360
- plus $851 from 7 others
What the payments were for
- Consulting fees$4,95026%
- Speaking & faculty fees$11,98862%
- Food & beverage$2,39712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conmed Corporation | 3 | $6,425 |
| Boston Scientific | 42 | $5,151 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $3,500 |
| Olympus Corporation | 4 | $2,575 |
| Fujifilm Healthcare Americas Corporation | 5 | $472 |
| Pentax Of America, Inc. | 9 | $360 |
| Vascular Technology, Inc. | 1 | $350 |
| Medtronic | 4 | $247 |
| Apollo Endosurgery US Inc | 1 | $100 |
| Olympus America Inc. | 2 | $45 |
| Johnson & Johnson(2 entities) | 2 | $43 |
| Laborie Medical Technologies Corp. | 1 | $38 |
| Steris Corporation | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$4,383
- GORE VIABIL$4,038
- XIFAXAN$3,500
- RELISTOR$2,000
- EVIS EXERA III VIDEO SYSTEM CENTER$1,030
- FUJIFILM$400
- PENTAX Medical$288
- INSPIRA$144
- C2 CryoBalloon Focal Controller$144
- C2 Cryoballoon$144
- ProdiGI$143
- EXALT$128
- OverStitch Endoscopic Suturing System$100
How this compares
$19,335 in reported general payments places this provider in the 80th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 27 | $33,563 |
| Pantoprazole Sodium | 19 | $373 |
| Omeprazole | 26 | $126 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Philadelphia
- Kuchikala ReddyPhiladelphia$6.5M
- Dina Halegoua de MarzioPhiladelphia$1.5M
- Gary FalkPhiladelphia$1.4M
- Kristle LynchPhiladelphia$1.3M
- Gary WuPhiladelphia$931K
- Faten AberraPhiladelphia$909K
- Ben StangerPhiladelphia$815K
- David KaplanPhiladelphia$737K
- Stacey PrennerPhiladelphia$577K
- Mark OstermanPhiladelphia$410K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.